NO2709651T3 - - Google Patents

Info

Publication number
NO2709651T3
NO2709651T3 NO12723811A NO12723811A NO2709651T3 NO 2709651 T3 NO2709651 T3 NO 2709651T3 NO 12723811 A NO12723811 A NO 12723811A NO 12723811 A NO12723811 A NO 12723811A NO 2709651 T3 NO2709651 T3 NO 2709651T3
Authority
NO
Norway
Application number
NO12723811A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2709651T3 publication Critical patent/NO2709651T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/208IL-12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
NO12723811A 2011-05-19 2012-05-21 NO2709651T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161487744P 2011-05-19 2011-05-19

Publications (1)

Publication Number Publication Date
NO2709651T3 true NO2709651T3 (no) 2018-03-03

Family

ID=46168653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12723811A NO2709651T3 (no) 2011-05-19 2012-05-21

Country Status (6)

Country Link
US (2) US20140314710A1 (no)
EP (1) EP2709651B1 (no)
CA (1) CA2836473C (no)
DK (1) DK2709651T3 (no)
NO (1) NO2709651T3 (no)
WO (1) WO2012159100A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2709651T3 (en) 2011-05-19 2018-01-08 Univ Rush Medical Center IL-12-P40 MONOMER, MONOCLONAL ANTIBODY AGAINST P40 HOMODIMER, AND A COMBINATION OF THE TWO FOR THE TREATMENT OF AUTO-IMMUNE DISEASE
CA2979210A1 (en) 2015-03-11 2016-09-15 Rush University Medical Center Compositions and methods for treating cancer
CN116528888A (zh) * 2020-10-30 2023-08-01 拉什大学医学中心 用于治疗阿尔兹海默症的鼻内免疫疗法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4315127A1 (de) * 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
CA2125763C (en) * 1993-07-02 2007-08-28 Maurice Kent Gately P40 homodimer of interleukin-12
ZA95960B (en) * 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
AU1407997A (en) * 1995-12-01 1997-06-19 Beth Israel Hospital Il-12 p40 subunit fusion polypeptides and uses thereof
PT1966238E (pt) * 2005-12-30 2012-07-31 Merck Patent Gmbh Uso de hsp70 como um regulador de atividade enzimática
US8563697B2 (en) * 2008-08-14 2013-10-22 Cephalon Australia Pty. Ltd. Anti-IL-12/IL-23 antibodies
DK2709651T3 (en) 2011-05-19 2018-01-08 Univ Rush Medical Center IL-12-P40 MONOMER, MONOCLONAL ANTIBODY AGAINST P40 HOMODIMER, AND A COMBINATION OF THE TWO FOR THE TREATMENT OF AUTO-IMMUNE DISEASE

Also Published As

Publication number Publication date
EP2709651A1 (en) 2014-03-26
US20140314710A1 (en) 2014-10-23
WO2012159100A1 (en) 2012-11-22
US20190008960A1 (en) 2019-01-10
CA2836473A1 (en) 2012-11-22
CA2836473C (en) 2020-07-14
US11045545B2 (en) 2021-06-29
EP2709651B1 (en) 2017-10-04
DK2709651T3 (en) 2018-01-08

Similar Documents

Publication Publication Date Title
BR112013022641A2 (no)
AP3853A (no)
BR112013027245A2 (no)
BR112013024383A2 (no)
BR112013026905A2 (no)
BR112013023185A2 (no)
BR112013022995A2 (no)
BR112013017670A2 (no)
BR112013026744A2 (no)
BR112013023927A2 (no)
BR112013027830A2 (no)
BR112013024365A2 (no)
BR112013027121A2 (no)
BR112013027452A2 (no)
AP2016009466A0 (no)
BR112013026790A2 (no)
BR112013024588A2 (no)
BR112013018949A2 (no)
BR112013026895A2 (no)
BR112013027761A2 (no)
BR112013021637A2 (no)
BR112013027836A2 (no)
BR112013025487A2 (no)
BR112013017878A2 (no)
BR112013027871A2 (no)